About
Sandra Glucksmann joined Adjuvant Capital as an Advisory Partner and Investment Committee member in 2023, and is CEO of Sensorium Therapeutics. She has over 30 years in biotech, serving as founding CEO and President of Cedilla Therapeutics and founding COO of Editas Medicine. She holds a Ph.D. in molecular genetics and cell biology from the University of Chicago.
Invests in
Biotech
Experience
- Rouge TherapeuticsBoard Executive Chaircurrent2025 β presentNetherlands
- Tufts University School of MedicineTUSM Board of Advisorscurrent2024 β presentBoston, Massachusetts, United States
- REGENXBIO Inc.Independent Board Membercurrent2018 β presentRockville, MD
- Adjuvant CapitalAdvisory Partnercurrent2023 β presentUnited States
- Edity TherapeuticsBoard Membercurrent2022 β presentRehovot, Israel
- Scenic BiotechSenior Advisorcurrent2024 β presentAmsterdam, North Holland, Netherlands
- Scenic BiotechIndependent Board Member2017 β 2024The Randstad, Netherlands
- Sensorium TherapeuticsBoard Member and Senior Advisor2025
- Sensorium TherapeuticsPresident & CEO2023 β 2025Boston, Massachusetts, United States
- Cedilla TherapeuticsPresident and CEO2018 β 2022Cambrdige, MA
- WEST - Women in the Enterprise of Science and TechnologyMember Board of Directors2017 β 2020Cambridge, MA
- WEST - Women in the Enterprise of Science and TechnologyChair Board of Directors2006 β 2017Cambridge, MA
- Third Rock VenturesEntrepreneur In Residence2017 β 2018
- Editas MedicineChief Operating Officer2013 β 2017
- TaconicIndependent Board Member2006 β 2015
- Cerulean PharmaSenior VP Research and Development2006 β 2013Cambridge, MA
- Cerulean PharmaSenior VP Research & Business Operations2006 β 2011
- Millennium PharmaceuticalsFrom Scientist to VP1993 β 2006
Education
- Massachusetts Institute of TechnologyPost-doctoral fellow, Molecular Biology1990 β 1993
- University of ChicagoPhD Molecular Genetics and Cell Biology1983 β 1989
- University of Wisconsin-MadisonBachelor of Science - BS
Skills & more
Research1Biotechnology32Lifesciences8Commercialization5Technology Transfer5Medical Devices3Molecular Biology7Biochemistry5Start-ups5Cross-functional Team Leadership4Oncology7Biopharmaceuticals16
+3 more
Drug DiscoveryProduct DevelopmentPharmaceutical IndustryLanguages Spanish
From Alexandra's professional profile.
Same school
Also attended Massachusetts Institute of Technology977
Fred WilsonCo-founder & Partner at Union Square VenturesAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsMatt HuangCo-founder and Managing Partner at ParadigmDelian AsparouhovPartner at Founders Fund and co-founder of Varda
+ 971 more
Also attended University of Chicago273
Mark SusterManaging Partner at Upfront VenturesShardul ShahInvestor at Index VenturesSam BlackmanEntrepreneur in Residence at GV (Google Ventures)Clay FisherInvestor at Spark CapitalJonas CiplickasPrincipal at Scale Venture PartnersJulia Gonzalez SandersPartner and General Counsel at Crosslink Capital
+ 267 more
Also attended University of Wisconsin-Madison194
Zhenyu TangInvestment Director at Intel CapitalDougAdvisor at Clear VenturesDan RuchPartner at Rho VenturesGeorge RobertsInvestor at OpenView Venture PartnersKevin WenzelAssociate at Marlin Equity PartnersSaar GurGeneral Partner at CRV (Charles River Ventures)
+ 188 more
Shared employers
Also worked at Tufts University School of Medicine2
Also worked at Scenic Biotech7
Edward van WezelManaging Partner at BioGeneration VenturesThijs Cohen TervaertPartner at InkefSimone BottiSenior Partner at InkefAndrew McLeanManaging Partner at Tin Alley VenturesAlexander VosVenture Partner at BioGeneration VenturesRianne EllenbroekPrincipal at BioGeneration Ventures
+ 1 more
Also worked at Third Rock Ventures79
Lisa PurcellInvestor at Third Rock VenturesPaul MeloneInvestor at Third Rock VenturesLee VeneziaInvestor at Third Rock VenturesKevin MunnellyInvestor at Third Rock VenturesAmanda ChanInvestor at Third Rock VenturesJigar RaythathaInvestor at Third Rock Ventures
+ 73 more
Also worked at Taconic1
Investments
Board seats
REGENXBIOScenic Biotech
Per the firm's website.
Colleagues at Adjuvant Capital
Abrar Haque
Associate at Adjuvant Capital
Christian Mandl
Senior Advisor at Adjuvant Capital
Curt LaBelle
Venture Partner at Adjuvant Capital
David Washer
Investor at Adjuvant Capital
Evelyn Yanatos
Director of Finance and Compliance at Adjuvant Capital
Gerard Cunningham
Operating Partner at Adjuvant Capital
Giulia Balconi
Associate at Adjuvant Capital
Glenn Rockman
Co-Founder and Partner at Adjuvant Capital




































